FTT - Opening SP when suspension is lifted, page-29

yes they will likely need shareholder approval


http://file:///C:/Users/james%20bratton/AppData/Local/Temp/2A1238449_FTT.pdf
Market Announcement24 July 202024 July 2020Market Announcement1/1ASX LimitedASX Customer Service Centre 131 279| asx.com.au Factor Therapeutics Limited (ASX: FTT) – Continued Suspension from Official QuotationDescriptionThe securities of Factor Therapeutics Limited (‘FTT’ will remain suspended from quotation, following the announcement that it has entered into a term sheet relating to the negotiation and potential implementation of a transaction to acquire certain products and technologies from Brain Biosciences, Inc trading as (DBA) LONGMILE Veterinary PET Imaging (the ‘Acquisition’. FTT’s securities will remain suspended until ASX is satisfied that all relevant information required under Guidance Note 12: Change to Activitieshas been announced to the market. If the Acquisition proceeds, ASX is likely to exercise its discretions under Listing Rule 11.1.2 to require the Acquisition to be conditional on approval by FTT’s ordinary security holders and under Listing Rule 11.1.3 to require FTT to recomply with Chapters 1 and 2 of the Listing Rules. If ASX is satisfied that FTT has provided sufficient information to enable its securities to be reinstated and security holders approve the Acquisition, it is expected that FTT’s securities will again be suspended from quotation immediately following such security holder approval and will remain suspended until FTT has recomplied with Chapters 1 and 2 of the Listing Rules.